Napsin a as a Marker of Clear Cell Ovarian Carcinoma

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-13-524
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Napsin a Is a Specific Marker for Ovarian Clear Cell Adenocarcinoma

Modern Pathology
Forensic MedicinePathology
2014English

Napsin-A Expression, a Reliable Immunohistochemical Marker for Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas

Iranian Journal of Pathology
Forensic MedicinePathology
2020English

Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma

Frontiers in Oncology
Cancer ResearchOncology
2020English

Cystatin B as a Potential Diagnostic Biomarker in Ovarian Clear Cell Carcinoma

International Journal of Oncology
Cancer ResearchOncology
2015English

Potential Targets for Ovarian Clear Cell Carcinoma: A Review of Updates and Future Perspectives

Cancer Cell International
Cancer ResearchOncologyGenetics
2015English

DNA Copy Numbers Profiles in Affinity-Purified Ovarian Clear Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2010English

Validation of 34betaE12 Immunoexpression in Clear Cell Papillary Renal Cell Carcinoma as a Sensitive Biomarker

Pathology
Forensic MedicinePathology
2017English

Cell-Free 59 kDa Immunoreactive Integrin-Linked Kinase: A Novel Marker for Ovarian Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2004English

MicroRNA-21 Is a Candidate Driver Gene for 17q23-25 Amplification in Ovarian Clear Cell Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy